Nobody in hospital procurement sets out to source from the wrong distributor. It usually starts with a budget conversation, a vendor offering a price that seems too good to ignore, or a time-pressured order where the usual channel isn’t available. The decision gets made quickly, the medicine arrives, and for a while nothing seems wrong. Until something does. The real cost of sourcing specialty medicines from an unverified or unsuitable Imported medicine distributor in Delhi rarely appears as a single dramatic event. It accumulates — in compromised patient outcomes, in wasted medicine, in regulatory exposure, and in the slow erosion of a procurement team’s credibility with the clinical staff who depend on them. Here is what that cost actually looks like, broken down into the categories that matter most.